SALT LAKE CITY, May 4, 2021 /PRNewswire/
-- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular
diagnostics company with a unique, patented platform for the
development of molecular diagnostic tests, announced today it will
release its first-quarter 2021 results on Thursday, May 13, 2021, after the market close.
The Company will also host a conference call and webcast on the
same day at 4:30 p.m. EDT to discuss
its financial results with analysts. Management on the call
will include Company CEO Dwight Egan
and CFO Brian Brown.
The call and webcast will be available via:
Webcast:
|
ir.codiagnostics.com on the Events &
Webcasts page
|
Conference
Call:
|
877-317-6789
(domestic) or 412-317-6789 (international)
|
If you are unable to participate during the live webcast, the
call will be recorded and later made available on the Company's
website.
About Co-Diagnostics, Inc.
Co-Diagnostics, Inc., a
Utah corporation, is a molecular
diagnostics company that develops, manufactures, and markets a new,
state-of-the-art diagnostics technology. The Company's technology
is utilized for tests that are designed using the detection and/or
analysis of nucleic acid molecules (DNA or RNA). The Company also
uses its proprietary technology to design specific tests to locate
genetic markers for use in industries other than infectious disease
and license the use of those tests to specific customers.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/co-diagnostics-inc-announces-first-quarter-2021-earnings-release-date-and-webcast-301283332.html
SOURCE Co-Diagnostics